Innovation Pharmaceuticals Inc. (IPIX)

USD 0.0

(0.0%)

Total Debt Summary of Innovation Pharmaceuticals Inc.

  • Innovation Pharmaceuticals Inc.'s latest annual total debt in 2023 was 268 Thousand USD , down -46.61% from previous year.
  • Innovation Pharmaceuticals Inc.'s latest quarterly total debt in 2024 Q1 was 238 Thousand USD , down -11.19% from previous quarter.
  • Innovation Pharmaceuticals Inc. reported annual total debt of 502 Thousand USD in 2022, down -73.18% from previous year.
  • Innovation Pharmaceuticals Inc. reported annual total debt of 1.87 Million USD in 2021, down -23.78% from previous year.
  • Innovation Pharmaceuticals Inc. reported quarterly total debt of 268 Thousand USD for 2023 Q4, down -22.54% from previous quarter.
  • Innovation Pharmaceuticals Inc. reported quarterly total debt of 393 Thousand USD for 2023 Q2, down -12.67% from previous quarter.

Annual Total Debt Chart of Innovation Pharmaceuticals Inc. (2023 - 2006)

Historical Annual Total Debt of Innovation Pharmaceuticals Inc. (2023 - 2006)

Year Total Debt Total Debt Growth
2023 268 Thousand USD -46.61%
2022 502 Thousand USD -73.18%
2021 1.87 Million USD -23.78%
2020 2.45 Million USD 27.78%
2019 1.92 Million USD -4.95%
2018 2.02 Million USD 0.0%
2017 2.02 Million USD 0.0%
2016 2.02 Million USD 0.0%
2015 2.02 Million USD 0.0%
2014 2.02 Million USD -50.01%
2013 4.04 Million USD 0.0%
2012 4.04 Million USD 683.35%
2011 516.31 Thousand USD -64.76%
2010 1.46 Million USD 238.93%
2009 432.31 Thousand USD 8.08%
2008 400 Thousand USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Total Debt Comparison of Innovation Pharmaceuticals Inc.

Name Total Debt Total Debt Difference
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 99.35%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 93.498%
SQZ Biotechnologies Company 27.47 Million USD 99.024%
Evofem Biosciences, Inc. 43.37 Million USD 99.382%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 99.1%
Mesoblast Limited 118.7 Million USD 99.774%
Propanc Biopharma, Inc. 948.27 Thousand USD 71.738%
Genus plc 233.1 Million USD 99.885%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 90.854%
CNBX Pharmaceuticals Inc. 1.34 Million USD 80.053%
Marizyme, Inc. 18.71 Million USD 98.568%
ContraFect Corporation 2.88 Million USD 90.698%
Nymox Pharmaceutical Corporation 750 Thousand USD 64.267%
PsyBio Therapeutics Corp. 135.48 Thousand USD -97.805%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD 81.47%
Intellipharmaceutics International Inc. 2.32 Million USD 88.478%
AXIM Biotechnologies, Inc. 5.65 Million USD 95.264%
MultiCell Technologies, Inc. 202.58 USD -132193.415%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 57.48 Million USD 99.534%
EV Biologics, Inc. 1.49 Million USD 82.071%
Q BioMed Inc. 4.1 Million USD 93.479%
Emmaus Life Sciences, Inc. 33.1 Million USD 99.19%
Neon Bloom, Inc. 630.07 Thousand USD 57.466%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 78.182%
Biomind Labs Inc. 735.54 Thousand USD 63.564%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 171.54 Million USD 99.844%
Oncotelic Therapeutics, Inc. 12.99 Million USD 97.938%
Skye Bioscience, Inc. 4.61 Million USD 94.193%
Therapeutic Solutions International, Inc. 888.06 Thousand USD 69.822%
THC Farmaceuticals, Inc. 141.51 Thousand USD -89.375%
Arch Therapeutics, Inc. 5.87 Million USD 95.435%
IMV Inc. 28.88 Million USD 99.072%
Acro Biomedical Co., Ltd. 25.71 Thousand USD -942.031%
Curative Biotechnology, Inc. 2.25 Million USD 88.133%
GB Sciences, Inc. 1.75 Million USD 84.767%
Alpha Cognition Inc. 1.22 Million USD 78.039%
HST Global, Inc. 98.31 Thousand USD -172.582%
CSL Limited 12.18 Billion USD 99.998%
Halberd Corporation 150 Thousand USD -78.667%
Enzolytics Inc. 996.33 Thousand USD 73.101%
Resverlogix Corp. 6.49 Million USD 95.871%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 477.5 Thousand USD 43.874%
Nuo Therapeutics, Inc. 255.59 Thousand USD -4.855%
argenx SE 20 Million USD 98.66%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 45.56 Million USD 99.412%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 90.106%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 10.22 Thousand USD -2521.027%
Genscript Biotech Corporation 417.73 Million USD 99.936%
Ember Therapeutics, Inc. 200.61 Thousand USD -33.589%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 88.823%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -16.882%
American Oriental Bioengineering, Inc. 67.64 Million USD 99.604%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 91.144%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation 359.71 Thousand USD 25.496%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 98.682%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD -80.284%
BioStem Technologies, Inc. 4.71 Million USD 94.312%
ONE Bio Corp. 19.71 Million USD 98.641%
Reve Technologies, Inc. 250.18 Thousand USD -7.122%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD -7.752%
Agentix Corp. 50 Thousand USD -436.0%
LadRx Corporation 33.6 Thousand USD -697.477%
Cell Source, Inc. 9.25 Million USD 97.104%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD 64.56%
Regen BioPharma, Inc. 756.2 Thousand USD 64.56%
NovAccess Global Inc. 2.19 Million USD 87.818%
Endonovo Therapeutics, Inc. 7.07 Million USD 96.211%
Itoco Inc. 228.37 Thousand USD -17.35%
Rasna Therapeutics, Inc. 210.97 Thousand USD -27.029%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 94.622%
Kadimastem Ltd 891.22 Thousand USD 69.929%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. 401.84 Thousand USD 33.308%
CytoDyn Inc. 30.07 Million USD 99.109%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD 44.661%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD 23.831%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 96.573%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 122.5 Thousand USD -118.776%
Rebus Holdings, Inc. 310 Thousand USD 13.548%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 94.34%
International Stem Cell Corporation 4.17 Million USD 93.585%
Bioxytran, Inc. 1.92 Million USD 86.078%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD -329.398%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 87.711%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 96.777%
Adhera Therapeutics, Inc. 8.58 Million USD 96.878%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 82.771%
Neutra Corp. 54.15 Thousand USD -394.867%
Windtree Therapeutics, Inc. 1.83 Million USD 85.355%
PureTech Health plc 25.51 Million USD 98.95%
Coeptis Therapeutics, Inc. 1.22 Million USD 78.109%
IXICO plc 472.02 Thousand USD 43.223%
IntelGenx Technologies Corp. 15.5 Million USD 98.271%
Gelesis Holdings, Inc. 62.26 Million USD 99.57%
CSL Limited 12.18 Billion USD 99.998%
Cellectis S.A. 92.77 Million USD 99.711%